Tonix Pharmaceuticals stock halted ahead of FDA approval news
Matthew Reade Miller, a director at Granite Ridge Resources, Inc. (NASDAQ:GRNT), purchased 18,700 shares of common stock on August 12, 2025, in a transaction valued at $100,232. The shares were bought at prices ranging from $5.34 to $5.37, with a weighted average price of $5.36. The purchase comes as the stock has shown strong momentum, gaining 8.7% in the past week, while offering an attractive dividend yield of 8.38%.
Following the transaction, Miller directly owns 1,284,064 shares of Granite Ridge Resources. According to InvestingPro analysis, the company, currently valued at $702 million, appears slightly undervalued based on its Fair Value metrics. Discover more insights about GRNT and 1,400+ other stocks with InvestingPro’s comprehensive research reports.
In other recent news, Granite Ridge Resources Inc (NYSE:GRNT) reported a strong performance in its Q2 2025 earnings call, highlighting a 20% year-over-year increase in total oil and gas sales revenue. The company also experienced a significant rise in production levels, which contributed to its positive financial results. Additionally, Granite Ridge raised its full-year production guidance, signaling confidence in its operational capabilities. These developments have fueled investor optimism about the company’s future prospects. While the stock price movement was notable, it is important to focus on the reported earnings and revenue figures. Analyst firms have taken note of the company’s performance, although specific upgrades or downgrades were not mentioned in the available context. Investors are paying close attention to these recent developments as they consider their positions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.